Life-threatening vasculo-Behcet following discontinuation of infliximab after three years of complete remission

Author(s):
Magro Checa, C.; Salvatierra, J.; Rosales-Alexander, J.L.; Orgaz-Molina, J.; Raya-Alvarez, E.
Published
2013
Publication type
Article / Letter to editor
Behcet's diseaseinfliximabthrombosisvasculitistumour necrosis factor-alpha inhibitors
Date issued
2013-06-30
Language
English
Is part of
Clinical and Experimental Rheumatology (2013), Vol. 31, no. 3, p. S96-S98
hdl
1887/114258